Cataracts; irritation in his eyes; Little weakness; moderate sleep apnea; upper respiratory issues; Tire more easily; migraine; more severe episodes of headaches; Posterior vitreous detachment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old male patient received bnt162b2 (BNT162B2), on 24Aug2021 as dose 2, single (Batch/Lot number: unknown), in arm for covid-19 immunisation. The patient's relevant medical history included: "Dizziness" (unspecified if ongoing), notes: started more than six years ago and it's the same; "Headache" (unspecified if ongoing), notes: he had for six years; "phobia" (unspecified if ongoing), notes: about eyes. The patient took concomitant medications. After getting the shot he is on a lot of other medications, but no additional details provided. Vaccination history included: bnt162b2 (Dose 1 (Covid 19 Pfizer age 12 plus purple cap), Lot: 295699,  Time: probably late morning or early afternoon, Administered in arm), administration date: 30Jul2021, for Covid-19 immunization. The following information was reported: VITREOUS DETACHMENT (medically significant) with onset Aug2021, outcome "not recovered", described as "Posterior vitreous detachment"; HEADACHE (non-serious) with onset 2022, outcome "unknown", described as "more severe episodes of headaches"; MIGRAINE (non-serious) with onset 2023, outcome "recovered" (2023); CATARACT (medically significant), outcome "not recovered", described as "Cataracts"; EYE IRRITATION (non-serious), outcome "unknown", described as "irritation in his eyes"; ASTHENIA (non-serious), outcome "not recovered", described as "Little weakness"; SLEEP APNOEA SYNDROME (non-serious), outcome "unknown", described as "moderate sleep apnea"; RESPIRATORY DISORDER (non-serious), outcome "unknown", described as "upper respiratory issues"; FATIGUE (non-serious), outcome "unknown", described as "Tire more easily". The events "posterior vitreous detachment", "cataracts" and "irritation in his eyes" required physician office visit. The patient underwent the following laboratory tests and procedures: Intraocular pressure test: unknown results, notes: he has a phobia about eyes and he allowed pressure test to happen; photographs/droplets and testing examination: unknown results; unknown results; conducting test: unknown results; Visual acuity tests: start or development of cataracts. Therapeutic measures were taken as a result of vitreous detachment, cataract. Additional information: patient had Posterior Vitreous Detachment (PVD), started in the left eye initially. This started approximately 2.5 to 3 days after getting the second Pfizer Vaccine. It occurred around noon time, was walking through a super market when started experiencing symptoms. When event first occurred he reported it to his primary physician who followed up and informed to see a retinas specialist on Monday who confirmed it was PVD. A few months later it started in his right eye. He had similar symptoms and the PVD was confirmed in his right eye. This is a permanent condition in both eyes now. With the PVD he had irritation that is either the same or slightly worse. This is in both eyes. He reiterated the PVD is severe in both eyes as he has constant floaters in both eyes which effects vision. After he was diagnosed with PVD he was diagnosed with cataracts and informed may need cataracts surgery in upcoming years. He does not know if cataracts is a side effects. The cataracts were diagnosed shortly after the PVD. A vision test was completed and it was detected he had the start or development of cataracts. However, reporter feels the cataracts may be due to age. He does not know if it's due to the vaccine. He does not know the exact date cataracts started just knows it was after 24Aug2021. Cataracts was same or possibly slightly worse. He just knows his vision has not improved. He further explained in regards to the irritation in his eyes he knows it's from the PVD, but does not know if it's from cataracts. Patient saw primary care. Has seen retina specialist a few times. They were conducting test. They took photographs. Did pressure test. He has a phobia about eyes and he allowed pressure test to happen. They did droplets and testing examination. He was told not to make sudden movements. Told to rest eyes. He had temporary shades over glasses. Informed not to get in too much sunlight. Also told not to make sudden abrupt movements of head for weeks because could cause a more more emergent situation. Reporter then added he also had some little weakness, it has been going on a year half to two years, it has been worse within the last year. He then added he had moderate sleep apnea and upper respiratory issues. He tires easily started after the shot. Over the last year had more severe episodes of headaches. A month or two ago he had a migraine where he saw spots in his vision. This migraine lasted 40 minutes. It was very pronounced and intense. Also some of the images were obstructed. He never went to the emergency room due to events experienced. He just saw the specialist and first time seeing the specialist was on Monday morning. He was able to be seen on an emergency basis.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.